Biofunctional evaluation of a hydrogen bond stabilizing the conformation in the cyclic part of oxytocin

Abstract

[5‐β‐Malamidic acid] oxytocin was synthesized to study the importance of the hydrogen bond between the C=O of Tyr2 and the peptide N‐H of Asn5 for the stabilization of a biologically functional conformation of oxytocin. This analog lacks the peptide N‐H at residue 5 required for the formation of a hydrogen bond with the C=O of Tyr2. [5‐β‐Malamidic acid] oxytocin exhibited 45.1 ± 2.5 U/mg and 65.6 ± 5.9 U/mg of uterotonic activity, in vitro, in the absence and in the presence, respectively, of Mg2+, 147 ± 14 U/mg of uterotonic activity in vivo, 203 ± 13 U/mg of milk‐ejecting activity, 0.37 ± 0.03 U/mg of pressor activity and 0.32 ± 0.29 U/mg of antidiuretic activity. It is concluded that devoid of the hydrogen bond under question, an oxytocin‐like peptide can still assume the conformation needed to interact with the oxytocin receptors.